ARCHIVES

FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity.

This article is from The Cancer Letter archive.

Vol. 26 No. 35 | September 29, 2000

Download PDF Visit The Full Archive

Related Articles

Budget Cut Asked By Ford Would Hold Grant Funding To 20%

January 10, 1975

ACCC Seeks Expanded Backing For CHOP, Other Community Cancer Programs

November 7, 1980

IOM Report Urges Providers To Address Psychological Needs Of Cancer Patients.

November 23, 2007

US Preventive Services Task Force To Downgrade PSA Screening From “I” to “D” — As In “Don’t Do it.”

October 6, 2011

Increased Breast Density Can Lead to Higher Risk

August 26, 2011

Senate Report Calls on NCI To Expand Research in Survivorship, CAM, GYN Cancers, And Fund Five Pancreatic SPOREs

August 2, 2002